The United Kingdom government has said that India’s Covaxin will be added to the list of approved COVID-19 vaccines for international travelers from November 22, meaning those vaccinated with the Bharat Biotech-made jab will have to self-quarantine after arrival in England. Doesn’t have to be separate.
The move follows the World Health Organization’s (WHO) emergency use list for Covaxin, the second most commonly used formulation in India.
India reported 10,126 new coronavirus infections, the lowest in 266 days, while the active cases stood at 1,40,638, the lowest in 263 days, according to data updated by the Union Health Ministry on Tuesday.
With the fresh cases, the total number of COVID-19 cases in the country rose to 3,43,77,113.
explained | Why are US COVID-19 vaccines still out of reach in India?
you can track coronavirus Cases, deaths and testing rates at the national and state levels Here, List state helpline number also available.
Here are the latest updates:
Tamil Nadu | 8:22 am
Madras High Court to relax COVID-19 restrictions from November 15
The Madras High Court has ordered the relaxation of several restrictions imposed for a long time to fight COVID-19. According to a notification issued by its Registrar General, the relaxation will be applicable from November 15.
The notification, issued on the directions of Chief Justice Sanjib Banerjee, said that all advocates and their registered clerks would be allowed to enter the High Court premises through all the four gates subject to adherence to the COVID-19 protocol.
However, the restriction on the entry of persons of litigants and parties, other than those who were specifically required by the court to be present for the hearing, shall continue. The cases will also be heard in hybrid/virtual/physical mode.
International | 7:42 am
WHO awaits oral, nasal COVID vaccines
The World Health Organization’s chief scientist said on Tuesday she was looking forward to a “second generation” of COVID-19 vaccines, which could include nasal sprays and oral versions.
Soumya Swaminathan said such vaccines could have an advantage over the current crop as they would be easier to deliver than injections and could even be self-administered.
Ms Swaminathan said there were 129 different candidate vaccines that have gone through clinical trials – being tested on humans – while 194 are still not advanced in their development and are still being worked on in laboratories. , AFP
USA | 7:40 am
Pfizer, BioNTech again seek US approval for COVID-19 vaccine booster in all adults
Pfizer Inc and BioNTech once again requested the US Food and Drug Administration (FDA) on Tuesday to authorize booster doses of their COVID-19 vaccine in all adults.
After a panel of agency advisors rejected Pfizer’s request for authorization of a booster in all individuals age 16 and older, the FDA in September banned people 65 and older and other individuals infected because of their jobs. Pfizer’s boosters were authorized for people at high risk of getting and above.
Panelists suggested that the evidence supporting widespread approval was insufficient, and they wanted to see more safety data, particularly concerning the risk of heart inflammation in young people after vaccination. , Reuters
National | 7:30 am
Increasing demand for portable oxygen cans in the country
After oxygen cylinders, it is the everyday use portable oxygen cans, which are now selling fast across the country, with the rise in air pollution levels and increase in travel and outdoor activities. It is also being used by those recovering from COVID-19.
According to industry experts, the sales of these portable oxygen cans have doubled post Diwali, and are expected to triple in the coming weeks considering the current trend.
Delhi-NCR alone claims to bring in 65% of the sales, while Mumbai, Bengaluru and Pune are also witnessing a steady rise in demand for this product. This is when physicians are unwilling to fully steer clear of the product, saying it may actually delay medical intervention and create a false sense of well-being.
Jammu and Kashmir | 7:29 am
J&K hospitals got bad ventilators
Jammu and Kashmir’s health and medical education has found itself in the dock after details received under the Right to Information (RTI) Act suggested that hospitals in the union territory be at least with the PM CARES fund last year. At least 165 “faulty” ventilators were supplied.
In response to an RTI application filed by activist Balwinder Singh, the Department of Anesthesiology and Critical Care Medicine of Shri Maharaja Hari Singh (SMHS) Hospital has reported that 165 ventilators – 37 from Bharat Ventilators, three from Agva Ventilators and 125 from Dhaman-III – were found to be defective.
The department wrote in its reply that all the machines of Bharat Ventilator were returned due to compressor and heat-up problem, as a result of which they suddenly stopped. “These ventilators do not support patient care management.”
Telangana | 7:28 am
Telangana | Clarity sought on COVID death certification
A day after the Telangana government notified district-level COVID-19 Death Assessment Committees (CDACs) to issue an ‘official document for COVID-19 deaths’, the panel members established the cause of deaths and other aspects. Clarity has been sought regarding the procedure to be done.
As per the guidelines issued by the National Disaster Management Authority, an ex-gratia of Rs 50000 is to be paid to the next of kin of the deceased, including those involved in relief work or in preparedness activities, provided the cause of death is certified. are going COVID-19.
With the state government issuing an order for the formation of CDAC on Monday, the demand for the COVID death document is expected to rise.
,